Ticker LaunchReverse merger · Completed · ENVB
Jay Pharma Inc.
Reverse merger with Ameri Holdings, Inc. (AMRH)
Jay Pharma Inc. merged into Ameri Holdings, Inc. (AMRH), a Nasdaq-listed SAP cloud and enterprise solutions services provider (business spun off), in a reverse merger that takes the private company public. The deal was announced on Jan 13, 2020 and closed on Dec 30, 2020. The combined company trades as Enveric Biosciences, Inc. (ENVB) on Nasdaq.
Enveric Biosciences develops cannabinoid-based palliative and wellness products for side effects of cancer and its treatment, such as skin reactions, pain, nausea and anxiety, using cannabinoid IP licensed from Tikun Olam.
- Status
- Completed
- Private company
- Jay Pharma Inc.
- Public company
- Ameri Holdings, Inc. (AMRH)
- Public company business before
- Nasdaq-listed SAP cloud and enterprise solutions services provider (business spun off)
- Announced
- Jan 13, 2020
- Closed
- Dec 30, 2020
- Combined company
- Enveric Biosciences, Inc. (ENVB)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Form 8-K (closing) Jan 6, 2021
- Press release (announcement)
- All filings on EDGAR CIK 890821
Other completed reverse mergers
- Summit Networks Inc.into Summit Networks Inc. · Jan 26, 2021
- Mycotopia Therapies, Inc.into 20/20 Global, Inc. · Jan 19, 2021
- Platinum International Biotech Co., Ltd.into Magna-Lab, Inc. · Jan 14, 2021
- Omnia Wellness Corporationinto Glolex, Inc. (renamed Omnia Wellness Inc.) · Jan 5, 2021
- Metuchen Pharmaceuticals LLCinto Neurotrope, Inc. · Dec 2, 2020
- Eagle Lake Laboratories, Inc.into Sollensys Corp. · Nov 30, 2020